Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus Placebo
Clinical trial NCT02657408 · COMPLETED
Trial details
- NCT number
- NCT02657408
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-11
- Primary completion
- 2017-02-14
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.